Medicine and Dentistry
Diseases
100%
Symptomatic Treatment
98%
Infection
69%
Amyotrophic Lateral Sclerosis
66%
End of Life Care
60%
COVID-19
58%
Methicillin Resistant Staphylococcus Aureus
54%
Neuropathy
53%
Clinician
48%
Health Care
48%
Polyneuropathy
48%
DeJerine-Sottas Disease
48%
Quality of Life
46%
Primary Health Care
41%
Neuromuscular Disease
38%
Physical Medicine and Rehabilitation
34%
Neurology
34%
Electrodiagnostic Medicine
33%
Cannabis
31%
Randomized Controlled Trial
31%
Prevalence
31%
Diabetic Nephropathy
30%
Health System
30%
Muscular Dystrophy
30%
Malignant Neoplasm
28%
Electrodiagnosis
28%
Public Health
26%
Magnetic Resonance Imaging
26%
Myotonic Dystrophy
25%
Odds Ratio
24%
Facioscapulohumeral Muscular Dystrophy
22%
Electronic Health Record
22%
Intensive Care Unit
22%
Medical Cannabis
21%
Weakness
21%
Outpatient
20%
Diabetes
20%
Electromyography
19%
Clostridium Difficile Infection
19%
Quality Improvement
18%
Clinical Trial
18%
Laboratory Test
18%
Antibiogram
18%
Bloodstream Infection
17%
Clinical Management
17%
Chronic Pain
17%
Health Care Cost
17%
Genetic Screening
17%
Antibiotics
16%
Clinical Research
16%
Mental Health
16%
Decision Making
15%
Dyspnea
15%
Duchenne Muscular Dystrophy
15%
Pathogen
15%
Wearable Sensor
15%
Spine Malformation
15%
Physical Activity
14%
Chronic Disease
14%
Musculoskeletal Disease
14%
Skin Biopsy
14%
Nerve Biopsy
14%
Dynamic Contrast-Enhanced MRI
14%
Breast Cancer
14%
Skeletal Muscle
14%
Antiinfective Agent
13%
Neuropathic Pain
13%
Drug Therapy
13%
Advance Directive
13%
Neoadjuvant Chemotherapy
13%
Comorbidity
13%
Pediatrics
13%
Real Time Polymerase Chain Reaction
13%
Cohort Effect
13%
Limb
13%
Traumatic Brain Injury
12%
Medicine
12%
Health Outcomes
12%
Logistic Regression Analysis
12%
Lung Function
12%
Analgesia
12%
Spinal Muscular Atrophy
12%
Muscle Contractility
12%
Dystrophy
12%
Patient Care
12%
Cohort Analysis
11%
Retrospective Cohort Study
11%
Clock Drawing Test
11%
Medical Record
11%
Nurse
11%
Apoplexy
11%
Cardiovascular System
11%
Motor Performance
11%
Treatment Response
11%
Intensive Care
11%
Mini-Mental State Examination
11%
Health Care Utilization
10%
Arm
10%
Muscle Injury
10%
Gram-Negative Bacteria
10%
Nursing and Health Professions
Diseases
99%
Palliative Therapy
78%
Quality of Life
73%
Neuromuscular Disease
60%
Infection
59%
Methicillin-Resistant Staphylococcus Aureus
56%
Health Care
45%
Chronic Pain
43%
Amyotrophic Lateral Sclerosis
42%
Cerebrovascular Accident
39%
Confidence Interval
37%
Terminal Care
35%
Prevalence
31%
Malignant Neoplasm
31%
Primary Medical Care
31%
Wearables
30%
Logistic Regression Analysis
28%
Nuclear Magnetic Resonance Imaging
27%
Intensive Care Unit
27%
Facioscapulohumeral Muscular Dystrophy
26%
Traumatic Brain Injury
25%
Health Care Personnel
25%
Cohort Analysis
24%
Spinal Cord Injury
24%
Odds Ratio
23%
Outpatient
23%
Mental Health
23%
Hospice Care
22%
Terminal Disease
20%
Pain Intensity
20%
Emergency Ward
20%
Cognitive Defect
20%
Health Outcomes
19%
Practice Guideline
18%
Functional Independence Measure
18%
Length of Stay
18%
General Practitioner
17%
Electronic Health Record
17%
Mini Mental State Examination
17%
Healthcare System
16%
Advanced Cancer
16%
Hospital Discharge
16%
Musculoskeletal Disease
16%
Myotonic Dystrophy
15%
Intensive Care
15%
Adverse Drug Reaction
15%
Total Quality Management
15%
Syndrome
15%
Bloodstream Infection
14%
Electronic Medical Record
14%
Health Care Utilization
14%
Sepsis
14%
Clostridium Difficile Infection
14%
Hereditary Motor Sensory Neuropathy
14%
Clock Drawing Test
14%
Neuropathy
14%
Urinary Tract Infection
14%
Medical Record
14%
Patient Care
14%
Duchenne Muscular Dystrophy
14%
Alzheimer's Disease
13%
Physiotherapist
13%
Infection Rate
13%
Neuropathic Pain
13%
Chronic Disease
12%
Hospital Readmission
12%
Emergency Care
12%
Short Form 36
12%
Hospital Infection
12%
Body Mass
12%
Dying
12%
Muscular Dystrophy
12%
Medication Therapy Management
11%
Severe Acute Respiratory Syndrome
11%
Community Hospital
11%
Sleep Time
11%
Weakness
11%
Antimicrobial Stewardship
10%
Real Time Polymerase Chain Reaction
10%
Social Support
10%
Psychological Functioning
10%
Patient Safety
10%
Methicillin Resistant Staphylococcus Aureus Infection
10%
Infection Control
10%
Long Term Care
10%
Catheter
10%
Receiver Operating Characteristic
9%
Predictive Value
9%
Angiographic Catheter
9%
Medical Cannabis
9%
Flu Like Syndrome
9%
Pharmacy Student
9%
Metabolic Syndrome X
9%
Antidepressant
9%
Post-Polio Syndrome
9%
Musculoskeletal Pain
9%
Infection Prevention
9%
Actimetry
9%
Ischemic Heart Disease
9%
Quality of Life Index
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
99%
Amyotrophic Lateral Sclerosis
71%
Infection
63%
Cannabis
41%
Clinical Trial
33%
Methicillin-Resistant Staphylococcus Aureus
32%
Prevalence
23%
Cerebrovascular Accident
22%
Medical Cannabis
21%
SARS Coronavirus
18%
Pharmacotherapy
18%
Infectious Agent
18%
Cohort Study
18%
Side Effect
16%
Diabetic Nephropathy
16%
Neoplasm
15%
Pharmacokinetics
15%
Antibiotics
15%
Coronavirinae
14%
Psychotomimetic
14%
Drug Interaction
14%
Carbon Dioxide
14%
Hereditary Motor Sensory Neuropathy
14%
Randomized Clinical Trial
14%
Hospital Infection
13%
Community Pharmacy
13%
Malignant Neoplasm
12%
Antimicrobial Resistance
12%
Quinolone Derivative
12%
Chemotherapy
12%
Placebo
12%
Ciprofloxacin
11%
Chronic Disease
11%
Antidepressant
11%
Staphylococcus Aureus
10%
Hemolysin
10%
Comorbidity
9%
Breast Cancer
9%
Natural Product
9%
Peptoclostridium difficile
9%
Quinolone
9%
Chronic Pain
9%
Systemic Mycosis
9%
Neuropathic Pain
9%
Streptococcus Agalactiae
9%
Clostridium Difficile Infection
9%
Neuroprotection
9%
Toll Like Receptor
9%
Phosphatase
9%
Modafinil
9%
Resveratrol
9%
Antiinfective Agent
9%
Myotonic Dystrophy
9%
Infection Rate
8%
Cannabinoid
8%
Nervous System Inflammation
8%
Mouse Model
8%
Amitriptyline
8%
Biological Marker
8%
sodium glucose cotransporter-2 inhibitors
7%
Buprenorphine Plus Naloxone
7%
Threonine
7%
Combination Drug
7%
Enterobacteriaceae
7%
Facioscapulohumeral Muscular Dystrophy
7%
Messenger RNA
7%
Neuromuscular Disease
7%
Cholinergic Receptor Blocking Agent
6%
Hospital Mortality
6%
Serine
6%
Bleaching Agent
6%
Healthcare Associated Infection
6%
Remdesivir
6%
Cardiovascular Disease
6%
Methicillin Resistant Staphylococcus Aureus Infection
6%
Neuropathy
6%
Protein Serine Threonine Kinase
6%
Antioxidant
6%
Clinical Feature
6%
Alzheimer's Disease
6%
Edema
6%
Asthma
6%
Enzyme Immunoassay
6%
Duchenne Muscular Dystrophy
6%
Muscle Weakness
6%
Neurologic Disease
6%
Tricyclic Antidepressant
5%
Muscular Dystrophy
5%
Acyltransferase
5%
Terminal Disease
5%
Analgesic Agent
5%
Hypoglycemia
5%
Functional Independence Measure
5%
Aminoglycoside
5%
Disease Exacerbation
5%
Posaconazole
5%
Contrast Medium
5%
Drug-Drug Interaction
5%
Receptor
5%
Inflammation
5%